Tag: GCP compliance

Budgeting for Translation and Interpretation in Study Financial Plans

November 14, 2025November 14, 2025 digi

Budgeting for Translation and Interpretation in Study Financial Plans Budgeting for Translation and Interpretation in Study Financial Plans The complexity of conducting oncology clinical research necessitates a well-structured financial plan, particularly concerning language access and translation services. This article aims to provide a detailed step-by-step guide on how to integrate budgeting for translation and interpretation…

Language Access & Translations

Aligning Global Messaging Across Languages While Respecting Local Nuance

November 14, 2025November 14, 2025 digi

Aligning Global Messaging Across Languages While Respecting Local Nuance Clinical trials operate within a global framework, requiring an intricate balance between standardized messaging and localized nuances, particularly in relation to language access and translation. For professionals in clinical operations, regulatory affairs, and medical affairs, achieving this iterative alignment is essential, especially in the context of…

Language Access & Translations

Common Translation Pitfalls That Trigger Ethics or Regulatory Findings

November 14, 2025November 14, 2025 digi

Common Translation Pitfalls That Trigger Ethics or Regulatory Findings In the realm of clinical trials, particularly in oncology clinical research, the importance of accurate and culturally sensitive translations cannot be overstated. As clinical operations, regulatory affairs, and medical affairs professionals navigate the maze of compliance and ethical challenges, understanding the potential pitfalls in translation processes…

Language Access & Translations

Recruitment Metrics That Reflect Diversity, Equity and Inclusion Goals

November 14, 2025November 14, 2025 digi

Recruitment Metrics That Reflect Diversity, Equity and Inclusion Goals Recruitment Metrics That Reflect Diversity, Equity and Inclusion Goals The importance of diversity, equity, and inclusion (DEI) in clinical trial recruitment is increasingly recognized as a vital component of ethical research and regulatory compliance. As clinical operations, regulatory affairs, and medical affairs professionals, it is crucial…

Equity in Recruitment & Fair Participant Selection

Site Feasibility and Location Choices as Drivers of Equity and Access

November 14, 2025November 14, 2025 digi

Site Feasibility and Location Choices as Drivers of Equity and Access Site Feasibility and Location Choices as Drivers of Equity and Access In the evolving landscape of clinical research and trials, ensuring equitable access to clinical trials continues to be a pressing issue. This comprehensive guide seeks to provide clinical operations, regulatory affairs, and medical…

Equity in Recruitment & Fair Participant Selection

Under-Representation of Specific Demographics: Identifying and Addressing Gaps

November 14, 2025November 14, 2025 digi

Under-Representation of Specific Demographics: Identifying and Addressing Gaps The global landscape of clinical research is rapidly evolving as regulatory authorities and stakeholders increasingly recognize the importance of diversity in clinical trials. Under-representation of specific demographics, particularly in clinical research related to conditions such as schizophrenia, poses significant ethical and scientific challenges. This comprehensive guide offers…

Equity in Recruitment & Fair Participant Selection

Payment Methods and Timing: Operationalizing Ethics Committee Guidance

November 14, 2025November 14, 2025 digi

Payment Methods and Timing: Operationalizing Ethics Committee Guidance In the ever-evolving landscape of clinical trial management, understanding and implementing the ethical guidance provided by regulatory authorities is crucial for clinical operations, regulatory affairs, and medical affairs professionals. This comprehensive guide aims to elucidate the operationalization of ethics committee guidance, especially focusing on compensation, reimbursement, and…

Compensation, Reimbursement & Undue Influence

Handling Travel, Time and Lost Wage Reimbursements Across Regions

November 14, 2025November 14, 2025 digi

Handling Travel, Time and Lost Wage Reimbursements Across Regions Handling Travel, Time and Lost Wage Reimbursements Across Regions In clinical trials, particularly those overseen by entities like Sanofi, ensuring proper reimbursement for participants’ travel, time, and lost wages is of paramount importance. This step-by-step guide aims to provide practical insights aimed at clinical operations, regulatory…

Compensation, Reimbursement & Undue Influence

Documenting the Rationale for Payment Models in Protocols and IRB Submissions

November 14, 2025November 14, 2025 digi

Documenting the Rationale for Payment Models in Protocols and IRB Submissions Documenting the Rationale for Payment Models in Protocols and IRB Submissions As clinical trials become increasingly patient-centric, it is essential for clinical research professionals to establish and document sound payment models within protocols and Institutional Review Board (IRB) submissions. Properly addressing compensation structures not…

Compensation, Reimbursement & Undue Influence

Benchmarking Compensation Across Studies and Therapeutic Areas

November 14, 2025November 14, 2025 digi

Benchmarking Compensation Across Studies and Therapeutic Areas Benchmarking Compensation Across Studies and Therapeutic Areas Compensation in clinical research is a multifaceted issue that encompasses ethical considerations, regulatory compliance, and operational logistics. It is essential for clinical operations, regulatory affairs, and medical affairs professionals to establish a fair and transparent compensation framework that addresses the needs…

Compensation, Reimbursement & Undue Influence